STRYKER CORP Excess Tax Benefit from Share-based Compensation, Operating Activities
STRYKER CORP (SYK) reported Excess Tax Benefit from Share-based Compensation, Operating Activities of $36.00 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-09.
Discontinued › Notes › Compensation Related Costs
us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities · last filed 2017-02-09
- STRYKER CORP excess tax benefit from share-based compensation, operating activities for the quarter ending 2016-12-31 was $5.00M, a 16.67% decline year-over-year.
- STRYKER CORP excess tax benefit from share-based compensation, operating activities for the quarter ending 2016-09-30 was $4.00M, a 300.00% increase year-over-year.
- STRYKER CORP excess tax benefit from share-based compensation, operating activities for the quarter ending 2015-12-31 was $6.00M.
- STRYKER CORP excess tax benefit from share-based compensation, operating activities for the quarter ending 2015-09-30 was $1.00M.
- STRYKER CORP excess tax benefit from share-based compensation, operating activities for fiscal 2016 was $36.00M, a 38.46% increase from fiscal 2015.
- STRYKER CORP excess tax benefit from share-based compensation, operating activities for fiscal 2015 was $26.00M, a 23.81% increase from fiscal 2014.
- STRYKER CORP excess tax benefit from share-based compensation, operating activities for fiscal 2014 was $21.00M.
- STRYKER CORP excess tax benefit from share-based compensation, operating activities for fiscal 2010 was $11.20M, a 62.32% increase from fiscal 2009.
| Period end | Excess Tax Benefit from Share-based Compensation, Operating Activities 3 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 6 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 9 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 9 month as first filed | Excess Tax Benefit from Share-based Compensation, Operating Activities 12 month |
|---|---|---|---|---|---|
| 2016-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-09 | $9.00M derived: sum of 2 quarters · filed 2017-02-09 | $36.00M 10-K · filed 2017-02-09 | ||
| 2016-09-30 | $4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $31.00M 10-Q · filed 2016-10-28 | |||
| 2016-06-30 | $27.00M 10-Q · filed 2016-07-22 | ||||
| 2015-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-09 | $7.00M derived: sum of 2 quarters · filed 2017-02-09 | $26.00M 10-K · filed 2017-02-09 | ||
| 2015-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $20.00M 10-Q · filed 2016-10-28 | |||
| 2015-06-30 | $19.00M 10-Q · filed 2016-07-22 | ||||
| 2014-12-31 | $21.00M 10-K · filed 2017-02-09 | ||||
| 2011-09-30 | $1.00M 10-Q · filed 2011-10-28 | $2.50M derived: sum of 2 quarters · filed 2011-10-28 | $6.00M 10-Q · filed 2011-10-28 | $6.00M derived: sum of 4 quarters · filed 2011-10-28 | |
| 2011-06-30 | $1.50M 10-Q · filed 2011-07-28 | $4.80M 10-Q · filed 2011-07-28 | $5.00M derived: sum of 3 quarters · filed 2011-07-28 | $5.10M derived: sum of 4 quarters · filed 2011-10-28 | |
| 2011-03-31 | $3.30M 10-Q · filed 2011-05-04 | $3.50M derived: sum of 2 quarters · filed 2011-05-04 | $3.60M derived: sum of 3 quarters · filed 2011-10-28 | $5.50M derived: sum of 4 quarters · filed 2011-10-28 | |
| 2010-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-18 | $300.00K derived: sum of 2 quarters · filed 2011-10-28 | $2.20M derived: sum of 3 quarters · filed 2011-10-28 | $11.20M 10-K · filed 2011-02-18 | |
| 2010-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | $2.00M derived: sum of 2 quarters · filed 2011-10-28 | $11.00M 10-Q · filed 2011-10-28 | $10.90M 10-Q · filed 2010-11-04 | $12.90M derived: sum of 4 quarters · filed 2011-10-28 |
| 2010-06-30 | $1.90M 10-Q · filed 2011-07-28 | $10.90M 10-Q · filed 2011-07-28 | $12.80M derived: sum of 3 quarters · filed 2011-07-28 | $13.60M derived: sum of 4 quarters · filed 2011-07-28 | |
| 2010-03-31 | $9.00M 10-Q · filed 2011-05-04 | $10.90M derived: sum of 2 quarters · filed 2011-05-04 | $11.70M derived: sum of 3 quarters · filed 2011-05-04 | $13.20M derived: sum of 4 quarters · filed 2011-05-04 | |
| 2009-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-18 | $2.70M derived: sum of 2 quarters · filed 2011-02-18 | $4.20M derived: sum of 3 quarters · filed 2011-02-18 | $6.90M 10-K · filed 2011-02-18 | |
| 2009-09-30 | $800.00K 10-Q · filed 2010-11-04 | $2.30M derived: sum of 2 quarters · filed 2010-11-04 | $5.00M 10-Q · filed 2010-11-04 | $15.00M derived: sum of 4 quarters · filed 2011-02-18 | |
| 2009-06-30 | $1.50M 10-Q · filed 2010-08-09 | $4.20M 10-Q · filed 2010-08-09 | $14.20M derived: sum of 3 quarters · filed 2011-02-18 | $29.10M derived: sum of 4 quarters · filed 2011-02-18 | |
| 2009-03-31 | $2.70M 10-Q · filed 2010-04-29 | $12.70M derived: sum of 2 quarters · filed 2011-02-18 | $27.60M derived: sum of 3 quarters · filed 2011-02-18 | $30.80M derived: sum of 4 quarters · filed 2011-02-18 | |
| 2008-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-18 | $24.90M derived: sum of 2 quarters · filed 2011-02-18 | $28.10M derived: sum of 3 quarters · filed 2011-02-18 | $33.70M 10-K · filed 2011-02-18 | |
| 2008-09-30 | $14.90M 10-Q · filed 2009-11-09 | $18.10M derived: sum of 2 quarters · filed 2009-11-09 | $23.70M 10-Q · filed 2009-11-09 | ||
| 2008-06-30 | $3.20M 10-Q/A · filed 2009-09-03 | $8.80M 10-Q/A · filed 2009-09-03 | |||
| 2007-12-31 | $43.50M 10-K · filed 2010-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |